Saratoga Investment Corp. NT 23 SAB
Set alert
25.62 USD 0.00 0.00%
As of Jan 8, 10:03 AM ET
25.62 Day range 25.74
25.67 52-week range 211,000.00
- Open
- 25.63
- Prev close
- 25.62
- Mkt cap
- 150.76M
- Vol
- 3.00K
- Avg vol
- 69.92K
- EPS
- 2.94
- P/E
- 8.73
- Div yield
- 0.00%
More statistics
- Low
- 25.62
- High
- 25.74
- Forward P/E
- 0.00
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 189,334.28
- 200-d avg
- 188,533.58
Key statistics
- Market cap
- 0
- Trailing P/E
- 8.73
- Forward P/E
- 0.00
- Price / sales
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- 50-day average
- 189,334.28
- 200-day average
- 188,533.58
News
- Orchestra BioMed Announces Virtue SAB Presentation at TCT 2026
- SAB BIO to Host Third Quarter 2026 Financial Results Conference Call and Webcast on November 5, 2026, 08:30 AM ET
- SAB Biotherapeutics Highlights Diabetes Trial Progress, Human Antibody Platform
- Orchestra BioMed to Host R&D Day Featuring Clinical Insights and Development Plans for AVIM Therapy and Virtue® SAB
- SAB BIO to Participate in Chardan 10th Annual Healthcare Conference
- SAB BIO Receives FDA Fast Track Designation for SAB-142 in Stage 3 Type 1 Diabetes
- SAB BIO to Present SAB-142 Data at the Inaugural Breakthrough T1D Clinical & Research Congress
- SAB BIO to Present SAB-142 Data at the 62nd Annual Meeting of the European Association for the Study of Diabetes
- SAB BIO to Participate in Upcoming Investor Conferences
- SAB Biotherapeutics Q2 Earnings Call Highlights
Your note
Sign in to keep a note on SAB — it syncs with the Stock Master app.